Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 174 Records) |
| Query Trace: Lymphoma and TP53[original query] |
|---|
| Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer science 2022 9 113 (11): 3972-3979. Usui Yoshiaki, Iwasaki Yusuke, Matsuo Keitaro, Endo Mikiko, Kamatani Yoichiro, Hirata Makoto, Sugano Kokichi, Yoshida Teruhiko, Matsuda Koichi, Murakami Yoshinori, Maeda Yoshinobu, Nakagawa Hidewaki, Momozawa Yukihi |
| Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers. British journal of haematology 2022 8 199 (3): 371-381. Petrackova Anna, Savara Jakub, Turcsanyi Peter, Gajdos Petr, Papajik Tomas, Kriegova E |
| Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nature communications 2022 Jul 13 (1): 3881. Burkhardt Birgit, Michgehl Ulf, Rohde Jonas, Erdmann Tabea, Berning Philipp, Reutter Katrin, Rohde Marius, Borkhardt Arndt, Burmeister Thomas, Dave Sandeep, Tzankov Alexandar, Dugas Martin, Sandmann Sarah, Fend Falko, Finger Jasmin, Mueller Stephanie, Gökbuget Nicola, Haferlach Torsten, Kern Wolfgang, Hartmann Wolfgang, Klapper Wolfram, Oschlies Ilske, Richter Julia, Kontny Udo, Lutz Mathias, Maecker-Kolhoff Britta, Ott German, Rosenwald Andreas, Siebert Reiner, von Stackelberg Arend, Strahm Brigitte, Woessmann Wilhelm, Zimmermann Martin, Zapukhlyak Myroslav, Grau Michael, Lenz Geo |
| Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions. Frontiers in oncology 2022 7 12 813158. Dai Yinghuan, Liu Ping, He Wenlong, Yang Lizhen, Ni Yang, Ma Xuejiao, Du Furong, Song Chao, Liu Yang, Sun |
| Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association. Blood advances 2022 Jul . Oishi Naoki, Satou Akira, Miyaoka Masashi, Kawashima Ichiro, Segawa Takahiro, Miyake Kunio, Mochizuki Kunio, Kirito Keita, Feldman Andrew L, Nakamura Naoya, Kondo Tets |
| Association of ATG16L1 rs2241880 and TP53 rs1042522 with characteristics and course of diffuse large B-cell lymphoma. Pathology, research and practice 2022 Jul 237 154033. Živanovi? An?elina, Stamatovi? Dragana, Streli? Nataša, Magi? Zvonko, Tarabar Olivera, Miljanovi? Olivera, Mišovi? Miroslav, ?uki? Svetlana, Cikota-Aleksi? Boja |
| Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations. Translational oncology 2022 7 23 101471. Canale Matteo, Petracci Elisabetta, Cravero Paola, Mariotti Marita, Minuti Gabriele, Metro Giulio, Ludovini Vienna, Baglivo Sara, Puccetti Maurizio, Dubini Alessandra, Martinelli Giovanni, Delmonte Angelo, Crinò Lucio, Ulivi Pao |
| APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations. Leukemia 2022 7 36 (9): 2269-2280. Hong Yuheng, Ren Tianyuan, Wang Xiaoxuan, Liu Xia, Fei Yue, Meng Shen, Han Xu, Sun Cong, Shen Hongru, Li Lanfang, Qiu Lihua, Qian Zhengzi, Zhou Shiyong, Zhang Huilai, Wang Xianh |
| Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome. British journal of haematology 2022 7 198 (6): 1016-1022. Favini Chiara, Talotta Donatella, Almasri Mohammad, Andorno Annalisa, Rasi Silvia, Adhinaveni Ramesh, Kogila Sreekar, Awikeh Bassel, Schipani Mattia, Boggione Paola, Mouhssine Samir, Ghanej Joseph, Al Essa Wael, Mahmoud Abdurraouf Mokhtar, Dondolin Riccardo, Alessa Nariman, Margiotta Casaluci Gloria, Boldorini Renzo, Gattei Valter, Gaidano Gianluca, Moia Riccar |
| Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma. Frontiers in oncology 2022 12 12 1003957. Guan Tao, Zhang Min, Liu Xiaolan, Li Jing, Xin Beibei, Ren Yanxin, Yang Yuchao, Wang Hui, Zhao Mengjing, Huang Yunpeng, Guo Xiaojing, Du Jun, Qian Wenbin, Su Lipi |
| Molecular determinants of clinical outcomes for anaplastic lymphoma kinase-positive non-small cell lung cancer in Chinese patients: A retrospective study. Cancer genetics 2022 12 270-271 32-38. Guan Maojing, Xu Jianping, Shi Qingmi |
| GENETIC SUBGROUPS INFORM ON PATHOBIOLOGY IN ADULT AND PEDIATRIC BURKITT LYMPHOMA. Blood 2022 10 . Thomas Nicole, Dreval Kostiantyn, Gerhard Daniela S, Hilton Laura K, Abramson Jeremy S, Barta Stefan K, Bartlett Nancy L, Bethony Jeffrey, Bhatia Kishor, Bowen Jay, Bryan Anthony C, Cesarman Ethel, Casper Corey, Cruz Manuela, Dyer Maureen, Farinha Pedro, Gastier-Foster Julie, Gerrie Alina S, Grande Bruno, Greiner Timothy C, Griner Nicholas, Gross Thomas G, Harris Nancy Lee, Irvin John D, Jaffe Elaine S, Henry David, Huppi Rebecca Liddell, Leal Fabio E, Lee Michael, Martin Jean Paul, Martin Marie-Reine, Mbulaiteye Sam M, Mitsuyasu Ronald, Morris Vivian, Mullighan Charles G, Mungall Andrew J, Mungall Karen, Mutyaba Innocent, Nokta Mostafa, Namirembe Constance, Noy Ariela, Ogwang Martin David, Omoding Abrahams, Orem Jackson, Ott German, Petrello Hilary, Pittaluga Stefania, Phelan James D, Ramos Juan Carlos, Ratner Lee, Reynolds Steven J, Rubinstein Paul G, Sissolak Gerhard, Slack Graham W, Soudi Shaghayegh, Swerdlow Steven Howard, Traverse-Glehen Alexandra, Wilson Wyndham, Wong Jasper Chun Hei, Yarchoan Robert, ZenKlusen Jean C, Marra Marco A, Staudt Louis M, Scott David W, Morin Ryan |
| Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing. Molecular carcinogenesis 2022 10 62 (2): 200-209. Hou Yue, Zi Jie, Liu Shuo, Ge Qinyu, Ge Zhe |
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. Experimental hematology & oncology 2022 Oct 11 (1): 71. Li Shan-Shan, Zhai Xiao-Hui, Liu Hai-Ling, Liu Ting-Zhi, Cao Tai-Yuan, Chen Dong-Mei, Xiao Le-Xin, Gan Xiao-Qin, Cheng Ke, Hong Wan-Jia, Huang Yan, Lian Yi-Fan, Xiao Ji |
| Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma. Leukemia & lymphoma 2022 10 64 (1): 140-150. Ma Guangyu, Gao Yuhuan, Jing Xiaotong, He Cuiying, Liu Haisheng, Wu Xiaolin, Gao Zhe, Li Yuan, Zhang Shengnan, Zhao Guim |
| Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 9 100323. Claudio Agostinelli, Luca Morandi, Simona Righi, Luigi Cirillo, Marica Iommi, Caterina Tonon, Diego Mazzatenta, Matteo Zoli, Maura Rossi, Gianmarco Bagnato, Alessandro Broccoli, Raffaele Lodi, Pier Luigi Zinzani, Elena Sabattini, Caterina Giannini, Sofia Asio |
| Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma. Annals of hematology 2023 9 . Osama Abd El Hameed Ebid, Lobna R Ezz El Arab, Amr S Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swell |
| Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. Cancer cell international 2023 8 23 (1): 187. Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo, Fang Wa |
| Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 8 . Luis Lara-Mejía, Andrés F Cardona, Luis Mas, Claudio Martín, Suraj Samtani, Luis Corrales, Graciela Cruz-Rico, Jordi Remon, Marco Galvez-Nino, Rossana Ruiz, Eduardo Rios-Garcia, Fernanda Tejada, Natalia Lozano-Vazquez, Rafael Rosell, Oscar Arrie |
| Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis (Alliance A151303). Blood advances 2023 7 . David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P Watkins, Felicia Gomez, Zachary L Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Nancy L Bartlett, Juan Pablo Alderuccio, Izidore S Lossos, Sarah L Ondrejka, Eric D Hsi, Peter Martin, John P Leonard, Malachi Griffith, Obi L Griffith, Todd A Fehnig |
| Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma. Blood advances 2023 6 . W Richard Burack, Hongli Li, Diana G Adlowitz, Janice M Spence, Lisa M Rimsza, Mazyar Shadman, Catherine Spier, Mark S Kaminski, John P Leonard, Michael Leblanc, Sonali M Smith, Jonathan W Friedbe |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
| TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy. Blood advances 2023 4 . William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E Lewis, Andrew D Zelenetz, M Lia Palomba, Matthew J Matasar, Ariela Noy, Audrey M Hamilton, Paul A Hamlin, Philip C Caron, David J Straus, Andrew M Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N Owens, Craig S Sauter, Lorenzo Falchi, Jennifer K Lue, Santosha A Vardhana, Gilles A Salles, Ahmet Dogan, Nikolaus D Schultz, Maria E Arcila, Steven M Horwi |
| MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
| Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
| Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar. Acta haematologica 2023 3 . Awata-Shiraiwa Maaya, Yokohama Akihiko, Kanai Yukihiro, Gotoh Nanami, Kasamatsu Tetsuhiro, Handa Hiroshi, Saitoh Takayuki, Murakami Hirokazu, Hirato Junko, Ikota Hayato, Tsukamoto Norifu |
| Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. Human genomics 2023 2 17 (1): 13. Yun Jiwon, Song Hyojin, Kim Sung-Min, Kim Soonok, Kwon Seok Ryun, Lee Young Eun, Jeong Dajeong, Park Jae Hyeon, Kwon Sunghoon, Yun Hongseok, Lee Dong So |
| Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 2023 1 . Michot Jean-Marie, Quivoron Cyril, Sarkozy Clémentine, Danu Alina, Lazarovici Julien, Saleh Khalil, El-Dakdouki Yolla, Goldschmidt Vincent, Bigenwald Camille, Dragani Matteo, Bahleda Rastislav, Baldini Capucine, Arfi-Rouche Julia, Martin-Romano Patricia, Tselikas Lambros, Gazzah Anas, Hollebecque Antoine, Lacroix Ludovic, Ghez David, Vergé Veronique, Marzac Christophe, Cotteret Sophie, Rahali Wassila, Soria Jean-Charles, Massard Christophe, Bernard Olivier A, Dartigues Peggy, Camara-Clayette Valérie, Ribrag Vince |
| [Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (12): 1010-1015. Shi Y F, Gao Z F, Li X H, Guo L G, Zheng Q L, Long M P, Deng L J, Du T T, Jia L, Zhao W, Song X X, Li |
| Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients. Clinical laboratory 2023 1 69 (1): . Wang HongBiao, Lin YingCheng, Li ZhiFeng, Wu YueRong, Yang ZhengYuan, Gao ShiHua, Lin FangFa |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: